As of January 22, 2025, Aquestive Therapeutics (AQST) has a market cap of $0.29 billion USD. According to our data, Aquestive Therapeutics is ranked No.6763 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.29 B |
-11.80%
|
Dec 31, 2024 | $0.32 B |
76.24%
|
Dec 29, 2023 | $0.18 B |
123.95%
|
Dec 30, 2022 | $82.24 M |
-76.81%
|
Dec 31, 2021 | $0.35 B |
-27.29%
|
Dec 31, 2020 | $0.49 B |
-8.08%
|
Dec 31, 2019 | $0.53 B |
-7.62%
|
Dec 31, 2018 | $0.57 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Ono Pharmaceutical
4528.T
|
$4.83 B |
-0.044 B
|
Japan
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Stryker Corporation
SYK
|
$148.83 B |
-0.003 M
|
USA
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Market Cap | = | AQST Stock Price | * | AQST Shares Outstanding |
= | $3.14 | * | 91.18 M | |
= | $0.29 B |